University of Toronto creates nanoparticles that reveal chemical differences through light

New nanoparticles detect disease markers 150 times brighter than existing tools, potentially lowering diagnostic costs globally

University of Toronto researchers developed dye-sensitized nanoparticles that emit green light when exposed to near-infrared radiation. These particles distinguish molecular isomers with near-identical structures—a capability critical for identifying disease markers at ultra-low concentrations. The technology achieves 150 times greater brightness than non-dye-sensitized upconversion nanoparticles and 50 times brighter than optimized conventional structures. They use ytterbium and erbium ions embedded in a lithium-lutetium-fluorine matrix, with a diamond-shaped core-shell-shell design that prevents energy leakage between ions. Published in the Journal of the American Chemical Society in September 2026, the work targets applications like pharmaceutical impurity detection and groundwater monitoring.

The nanoparticles’ sensitivity could enable cheaper, more accessible diagnostics by reducing the need for expensive equipment. However, the technology remains in research and has not yet been deployed in real-world diagnostic settings. Current applications are potential future uses, not active implementations.

What matters next: Real-world testing of diagnostic use cases, cost of near-infrared lasers for activation, and whether molecular isomer distinction can scale beyond specific structural comparisons. The source notes this technology could enable cheaper diagnostics but remains unproven at scale—its impact on global health access depends on overcoming these barriers without overpromising.

Source: ScienceDaily